Clare Namayanja is a regulatory affairs specialist at the National Drug Authority (NDA) in Uganda, where she contributes to the oversight and regulation of pharmaceutical products. Holding a masters degree, she possesses a strong understanding of the Convention on Biological Diversity (CBD) and the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from Their Utilisation (ABS). Clare has actively participated in ABS engagements organised by Makerere University through its ABS project, enhancing her expertise in the sustainable use and equitable sharing of benefits arising from the utilisation of genetic resources. Her work ensures that pharmaceutical practices align with national and international biodiversity governance frameworks.
